Search

Filters
Clear All
  • 13
  • 49
  • 619

Phase

  • 10
  • 16
  • 55
  • 9
  • 74
  • 3
  • 500
  • 595
  • 281
  • 668
  • 13
  • 2
  • 679

Found 681 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
R
Raj Vuppalanchi, MD
18 years - 100 years
All genders
Interventional
This study investigates metabolic dysfunction-associated steatotic liver disease (MASLD), a condition where fat builds up in the liver due to metabolic issues. The purpose of this study is to assess the safety and effectiveness of different investigational medications for adults with MASLD who are at high risk of serious liver …
E
Eric Orman
18 years - 100 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on hereditary hemochromatosis, a condition where the body absorbs too much iron from food, leading to excess iron storage in organs. The purpose of this study is to evaluate how the investigational medication affects liver iron concentration (LIC) in adults with …
R
Raj Vuppalanchi, MD
18 years - 75 years
All genders
Phase 3
Interventional
This study investigates the safety and effects of an investigational medication for people with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and liver fibrosis at stages F2 or F3. MASH is a liver condition where fat builds up in the liver, causing inflammation and damage. The purpose of this study is to see …
A
Anthony Ross
180 days - 22 years
All genders
Phase 2
Interventional
This study investigates an investigational medication for treating Langerhans cell histiocytosis (LCH), a disease where the body makes too many immature Langerhans cells, a type of white blood cell. These cells can build up and form tumors in organs like bones, skin, and lungs, causing damage. The purpose of the …
R
Rachael Schulte
2 years or above
All genders
Phase 2
Interventional
This study investigates a treatment for PIK3CA Related Overgrowth Spectrum (PROS), a condition caused by a mutation in the PIK3CA gene that leads to abnormal growths in the body. The purpose of this study is to evaluate the safety and effectiveness of an investigational medication targeting these mutations.Participants in this …
M
Martin Kaefer, MD
100 years or below
All genders
Interventional
What is the purpose of this study?Aim 1. Compare the effect of the Hypospadias Hub Intervention vs. control on the quality of SDM. Aim 2. Compare the effect of the Hypospadias Hub Decision Support Intervention vs. control on decisional conflict, decision-relevant knowledge, and decisional regret. Aim 3. Assess barriers and …
A
Amir Hajrasouliha
D
Denis Jusufbegovic, MD
18 years - 100 years
All genders
Interventional
This study investigates the treatment of proliferative diabetic retinopathy (PDR), which is an eye condition caused by diabetes that can lead to vision loss. The purpose of this study is to compare two treatment strategies: a combination of an investigational medication with panretinal photocoagulation (PRP) and a surgical procedure called …
A
Adam Comer
16 years - 17 years
All genders
Phase 3
Interventional
This study investigates the long-term effects of an investigational medication for Myotonic Dystrophy Type 1 (DM1). DM1 is a genetic disorder that affects muscle function and can cause muscle weakness and stiffness. This study aims to understand how the investigational medication affects people with DM1 over a long period.Participants will …
A
Amanda J. Saraf, DO
1 year or below
All genders
Phase 2
This study investigates the addition of investigational medication and investigational immunotherapy to the usual chemotherapy for infants with newly diagnosed acute lymphoblastic leukemia (ALL). ALL is a type of cancer where the bone marrow makes too many immature lymphocytes (a type of white blood cell). In this study, the researchers …
J
Jonathan L. Berkowitz, MD, PhD
18 years or above
All genders
Interventional
This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as the usual …
571 - 580 of 681